Remove Diabetes Remove Documentation Remove HIPAA
article thumbnail

Top 10 RPM Vendors 2025: Driving Results in Remote Patient Monitoring

PharmD Live

PharmD Live’s board-certified clinical pharmacists manage and monitor the RPM service, record and document patient health metrics, and provide monthly billing reports, reducing provider workload without sacrificing care. Smith’s primary care provider, discontinued the problematic medication, and initiated a safer pain management plan.

HIPAA 52
article thumbnail

How Is AI Changing Pharma Marketing: What Brand Teams Need to Know

Pharma Marketing Network

These techniques are already being tested in diabetes education, oncology, and rare diseaseswhere onboarding and persistence are especially critical. Therefore, marketers must prioritize transparency, document algorithms decision-making logic, and maintain robust audit trails. Patients, too, benefit from this smarter targeting.

HIPAA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What is Digital Communication: Comprehensive Explanation with Examples

Viseven

Studies reveal that virtual care has had a significant impact on managing chronic diseases like diabetes. Research backs this up too — studies show that when patients can access health information in ways that click with them, they feel more confident managing their health, especially with ongoing conditions like diabetes or heart disease.

article thumbnail

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

Enhance Dialogue-Based Engagement Clarify Required Disclosures Allow HIPAA Waivers if Feasible Clarify Speaker Selection Process Allow for Data Submissions After Sessions Increase Engagement. Similarly, long-acting insulin analogs provide more stable blood sugar control and reduce the number of daily injections needed for diabetes patients.